1 |
윤은정, 김현지, 권애란, 최성숙, 심미자, 최응칠. 2006. 안개형 저지원을 갖는 MLS 내성 황색포도상 구균의 내성 기전. 약학회지 50, 199-203
과학기술학회마을
|
2 |
Asano, Y., A. Nakazawa, Y. Kato, and K. Kondo. 1989. Properties of a noble D-stereospecific aminopeptidase from Ochrobactrum anthropi. J. Biol. Chem. 264, 14233-14239
|
3 |
Babic, M., A.M. Hujer, and R. Bonomo. 2006. What's new in antibiotic resistance? Focus on -lactamase. Drug resist. Updates 9, 142-156
DOI
ScienceOn
|
4 |
Baek, D.H., S.J. Kwon, J.S. Park, S.G. Lee, n. Mheen, and M.H. Sung. 1999. Discovery of D-stereospecific dipeptidase from thermophilic Bacillus sp. BCS-l and its application for synthesis of Damino acid containing peptide. J. Microbiol. Biotechnol. 9, 646-649
|
5 |
Bambeke, F., M. Chauvel, P.E. Reynolds, H.Y. Fraimow, and P. Courvalin. 1999. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants. Antimicrob. Agents Chemother. 43, 41-47
DOI
|
6 |
Dmitriev, B., F. Toukach, and S. Ehlers. 2005. Towards a comprehensive view of the Bacteriol cell wall. Trends Microbiol. 13, 569-574
DOI
ScienceOn
|
7 |
El-Naggar, M.Y., S.A. El-Assar, and S.M. Abdul-Gawad. 2006. Meroparamycin production by newly isolated Streptomyces sp. strain MAR01: taxonomy, fermentation, purification and structural elucidation. J. Microbiol. 44, 432-438
과학기술학회마을
|
8 |
Fathalla, O.A., S.M. Awad, and M.S. Mohamed. 2005. Synthesis of new 2-thiouracil-5-sulphonamide derivatives with antiBacteriol and antifungal activity. Arch. Pharm. Res. 28, 1205-1212
과학기술학회마을
DOI
|
9 |
Fraise, A.P. 2006. Tiecycline: The answer to beta-lactam and fluoroquinolone resistance? J. Infec. 53, 293-300
DOI
ScienceOn
|
10 |
Gill, M.J., N.P. Brenwald, and R. Wise. 1999. Identification of an efflux pump gene, pmrA, associated with tluoroquinolone resistance in Streptococcus pnuernoniae. Antimicrob. Agents Chemother. 43, 187-189
DOI
|
11 |
Hedge, V., M. Patel, A. Horan, V. Gullo, and J. Marquez. 1992. Macrolactams: A novel class of antifungal antibiotics produced by Actinomadura spp. J. Antibiotics (Tokyo) 45, 624-632
DOI
|
12 |
Mine, T., Y. Morita, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1999. Expression in Escherichia coli of a new multidrug efflux pump MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 415-417
DOI
|
13 |
Johnson, D.M., M.G. Stilwell, T.R. Fritsche, and R.J. Jones. 2006. Emergence of multidrug-resistnat Streptococcus pneumoniae: report from the SENTRY antiMicrobiol surveillance Program(1999-2003). Diagnostic Microbiol. Infect. Dis. 56, 69-74
DOI
ScienceOn
|
14 |
Knapp, J.S., J.M. Zenilman, J.W. Biddle, G.H. Perkins, W.E. DeWitt, M.L. Thomas, S.R. Johnson, and S.A. Morse. 1987. Frequency and distribution in the United States of strains of Neisseriae gonorrhoeae with plasmid mediated, high level resistance to tetracycline. J. Infect. Dis. 155, 819-822
DOI
ScienceOn
|
15 |
Madigan, M.T., J.M. Martinko, and J. Packer. 2003. Brock's Biology of Microorganims (10th), p. 75-79, Prentice Hall, Upper Saddle River, NJ, USA
|
16 |
Selwyn, Q., T. Imai, Y. Mikaml, K. Yazawa, E.R. Dabbs, N. Morisaki, S. Iwasaki, Y. Hashimoro, and K. Furihata. 1999. ADP-ribosylation as an intermediate step in inactivation of rifampin by a Mycobacterial gene. Antimicrob. Agents Chemother. 43, 181-184
|
17 |
임상수, 김미광, 민정범, 김민정, 박순낭, 황호길, 국중기. 2006. 감염근관에서 분리 배양한 세균의 수종 항생제에 대한 감수성 조사. 미생물학회지 42, 185-194
과학기술학회마을
|
18 |
Fanuel, L., I. Thamm, V. Kostanjevecki, B. Joris, C. Goffin, J. Brannigan, J. van Beeumen, and J.M. Frere. 1999. Two new aminopeptidase from Ochrobactrum anthropi active on D-alanly-pnitroanilide. Cell Mol. Life. Sci. 55, 812-818
DOI
ScienceOn
|
19 |
Hasegawa, T., M. Kakushima, M. Hatori, S. Aburaki, S. Kakimura, T. Furumai, and T. Oki. 1993. Pradimicins T1 and T2, New antifungal antibiotics produced by an Actinomyces II. Structure and biosynthesis. J. Antibiotics (Tokyo) 46, 598-605
DOI
ScienceOn
|
20 |
윤은정, 윤종민, 최성숙, 권애란, 심미자, 최응칠. 2006. 임상분리 그람 양성 구균에 대한 MLS계 항생물질의 내성. 약학회지 50, 204-207
과학기술학회마을
|
21 |
Rao, M.B., A.M. Tanksale, M.S. Ghatge, and V.V. Deshpande. 1998. Molecular and biotechnological aspects of Microbiol protease. Microbiol. Mol. Biol. Rev. 62, 597-635
|
22 |
Ormerod, L.P., J.M. Harrison, and P.A. Wright. 1990. Drug resistance trend in Mycobacterium tuberculosis: Blackburn 1985-89. Tubercle 71, 283
DOI
ScienceOn
|
23 |
Rajasekaran, A., S. Murugesan, and K. Anandarajagopal. 2006. AntiBacteriol, antifungal and anticovulsant evaluation of novel newly synthesized 1-[2-(1H-tetrazol-5-yl)ethyl]-1H-benzo[d][1,2,3]triazoles. Arch. Pharm. Res. 29, 535-540
과학기술학회마을
DOI
|
24 |
Asano, Y., H. Ito, T. Dairi, and Y. Kato. 1996. An alkaline D-stereospecific endopeptidase with D-lactamases activity from Bacillus cereus. J. Biol. Chem. 271, 30256-30262
DOI
ScienceOn
|
25 |
Paulsen, I.T., M.H. Brown, and R.A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60, 575-608
|
26 |
Zhao, P-J., L-M. Fan, G-H. Li, N. Zhu, and Y-M. Shen. 2005. Antibacterial and antitumor macrolides from Streptomyces sp. Is9131. Arch. Pharm. Res. 28, 1228-1232
과학기술학회마을
DOI
|
27 |
Sieradzki, K. and A. Tomasz. 2003. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J. Bacteriol. 185, 103-7110
|
28 |
Amsterdam, D. 1992. Susceptibility. p. 161-163. In J. Lederberg(ed.), Encyclopedia of Microbiology. Vol. 4. Academic Press, Tokyo, Japan
|
29 |
Baron, E.J., R.S. Chang, D.H. Howard, J.N. Miller, and J.A. Turner. 1993. Medical Microbiology. A short course, p. 397-399, Wiley-Liss. New York, USA
|
30 |
이동석. 2005. 필수임상미생물학, p. 32-35, 라이프사이언스, 서울
|
31 |
Sin, E., H.-G. Hong, Y. Ike, K. Lee, Y.H. Park, D.T. Lee, and Y. Lee. 2006. VanB-VanA incongruent VRE isolated from animals and humans in 1999. J. Microbiol. 44, 453-456
과학기술학회마을
|
32 |
Asano, Y., Y. Kato, A. Yamada, and K. Kondo. 1992. Structural similarity of D-aminopeptidase to carboxypeptidase DD and -lactamases. Biochemistry 31, 2316-2328
DOI
ScienceOn
|
33 |
Kim, B.S. and B.K. Hwang. 1993. Production, purification and antifungal activity of antibiotic substances produced by Pseudomonas aeruginosa strain B5. Kor. J. Appl. Microbiol. Biotechnol. 3, 12-18
|
34 |
Song, J.S. 2002. Master's Thesis. Chungbuk National University, Cheongju
|
35 |
Omura, S. 1992. The Search for bioactive compounds from microorganisms. Springer-Verlag, Tokyo, Japan
|
36 |
Hoban, D.J., S.K. Bouchillon, J.L. Johnson, G.G. Zhanel, D.L. Bulter, K.A. Saunders, L.A. Miller, J.A. Poupard, and the Surveillance Study Research Group. 2003. Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against North American clinical isolates from a global surveillance study. Int. J. Antimicrob. Agents 21, 425-433
DOI
ScienceOn
|
37 |
Walsh, C. 2003. Natural and producer immunity versus acquired resistance, pp. 91-106. In Antibiotics, actions, origins, resistance. ASM Press, Washington DC, USA
|
38 |
Dmitriev, B., E.V. Toukach, O. Holst, E.T. Rietchel, and S. Ehlers. 2004. Tertiary structure of Staphylococcus aureus cell wall murein. J. Bacteriol. 186, 7141-7148
DOI
ScienceOn
|
39 |
Silver, L.L. and K.A. Bostian. 1993. Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrob. Agents Chemother. 37, 377-383
DOI
ScienceOn
|
40 |
Baglan, P., H.G. Bozdayi, M. Ozkan, K. Ahmed, A.M. Bozdayi, and A. Ozden. 2006. Clarithromycin resistance prevalence and Icea Gene status in Helicobacter pyroli clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J. Microbiol. 44, 409-416
과학기술학회마을
|
41 |
Ban. O.-H., S.-S. Han, and Y.N. Lee. 2003. Identification of a potent protease producing bacterial isolate, Bacillus amyloliquefaciens CMB01. Ann. Microbiol. 53, 95-103
|
42 |
Song, J.S. and Y.N. Lee. 2002. Purification and characterization of D-alaninepepdidase from Bacillus amyloliquefaciens CMB01. p.248, Abstr. 9th Int. Sym. Gen. Ind. Microorg. Gyeongju, 2002
|
43 |
Holtje, J.-V. 1998. Growth of the stress bearing and shape maintaining murein sacchulus of Escherichia coli. Microbiol. Mol. Biol. Rev. 62, 181-203
|
44 |
Harold, J.B. 1985. AntiMicrobiol sensitivity testing, p. 138-144. In Microbiological Applications. Wm. C. Brown Publishers, New York, USA
|